Atypical Testing in the Viral Era - Takeaways - MDSpire

Atypical Testing in the Viral Era

Study questions routine testing for atypical bacterial co-infection in viral respiratory hospitalizations

  • By

  • Conexiant News Staff

  • February 2, 2026

  • 3 min

Share

  • 1

    Routine testing for atypical bacterial co-infections in viral respiratory infections shows limited value, according to a Danish cohort study.

  • 2

    Only 1% of patients tested for atypical bacteria had positive results, indicating low prevalence of co-infection.

  • 3

    Despite low co-infection rates, 4% of patients received empirical clarithromycin within 48 hours of admission.

  • 4

    Most patients with confirmed atypical bacterial co-infection did not receive early macrolide therapy before test results.

  • 5

    The study suggests that routine testing and treatment for atypical pneumonia in viral infections is not supported by current guidelines.

Original Source(s)

Atypical Testing in the Viral Era

  • by Conexiant News Staff

  • February 2, 2026

Related Content

Side Effects: Salt, Steroids, and Second Brains

So get this: sodium may track with memory decline (in men), steroids might not be “immunosuppressive” in the ICU, and second pregnancies reshape the brain differently than first. Same theme: biology is less binary than we teach it.

Pediatric meningoencephalitis in the molecular diagnostic era: epidemiological insights from 1198 suspected cases in Germany between 2016 and 2024

FDA Approves Expanded Liquid Biopsy Panel

Updated liquid biopsy combines genomic and epigenomic profiling for companion diagnostic use across multiple tumor types.